You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG …

Article metrics

Article menu
XML
Immune cell therapies and immune cell engineering
Original research
Combinatorial immunotherapy of N-803 (IL-15 superagonist) and dinutuximab with ex vivo expanded natural killer cells significantly enhances in vitro cytotoxicity against GD2+ pediatric solid tumors and in vivo survival of xenografted immunodeficient NSG mice

 

Online download statistics by month:

Online download statistics by month: July 2021 to September 2025

AbstractFullPdf
Jul 2021603604275
Aug 2021260259104
Sep 202116216189
Oct 202112012057
Nov 202111411136
Dec 2021949672
Jan 2022777951
Feb 2022859276
Mar 202211111972
Apr 202213114666
May 2022818652
Jun 202211511850
Jul 202211412049
Aug 202212513243
Sep 202211812660
Oct 2022899353
Nov 202210110056
Dec 2022686836
Jan 202310610658
Feb 202313714059
Mar 2023889180
Apr 2023747446
May 2023808153
Jun 2023717139
Jul 2023565739
Aug 202310611044
Sep 202314914930
Oct 2023787822
Nov 202310510542
Dec 2023596039
Jan 2024485246
Feb 2024616134
Mar 202412212245
Apr 202412612664
May 202411311357
Jun 2024939240
Jul 202413513752
Aug 2024797642
Sep 20246565217
Oct 2024686847
Nov 2024787932
Dec 202416116446
Jan 202511611666
Feb 2025929359
Mar 2025737354
Apr 202512712840
May 202513813862
Jun 2025787933
Jul 2025110
Sep 2025110
Total545255362884